Castuner

JACC Global

American College of Cardiology

Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.

Sito del podcast

Ascoltalo nella tua app

Episodi

93 episodi

  1. ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 34:25
  2. ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 34:25
  3. Does PFA Reach the Vein of Marshall? | JACC Baran 36:20
  4. A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran 28:08
  5. Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran 35:48
  6. PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran 36:38
  7. Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran 39:47
  8. PFA Changes the Game and the AT Circuit | JACC Baran 36:55
  9. Is “Normal” Hemoglobin Really Normal in Heart Failure? | JACC Baran 33:28
  10. BRIDGING the Lipid Management Gap After ACS: ESC Late-Breaker | JACC Baran 43:20
  11. ESC 2026 Special: JACC SimPub Papers You Should Know | JACC Baran 36:26
  12. The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran 47:48
  13. HFpEF: Why Earlier May Be Better | JACC Baran 38:20
  14. Post-PCI Hematoma: What IVUS Tells Us | JACC Baran 35:03
  15. Pediatric Heart Transplantation: When Priority Doesn't Match Urgency | JACC Baran 35:03
  16. PACs: Benign Bystanders or AF in Disguise? | JACC Baran 35:47
  17. Cancer VTE + DOAC: Who Will Bleed? | JACC Baran 39:48
  18. HFpEF Without Obesity: What Coronary Microcirculation Tells Us | JACC Baran 37:50
  19. What Autopsy Reveals About MINOCA and Sudden Cardiac Death | JACC Baran 45:32
  20. Remnant Cholesterol: Small Name, Big ASCVD Risk | JACC Baran 42:20
  21. Post-AF Ablation Anticoagulation: How Long Is Long Enough? | JACC Baran 44:30
  22. Ultra-Low-Dose CAC in the Photon-Counting Era | JACC Baran 33:14
  23. The Rise of PROs: What Traditional Risk Scores May Be Missing | JACC Baran 36:09
  24. After PCI, What Matters Most? Heart Failure, Bleeding, or Recurrent MI? | JACC Baran 35:42
  25. HFpEF and HFmrEF: Can KCCQ-12 Replace KCCQ-23? | JACC Baran 33:51
  26. Can AI Predict AF Recurrence After Cardioversion? | JACC Baran 32:32
  27. Mitral Stenosis: Beyond Rheumatic Disease | JACC Baran 31:20
  28. AF Ablation and the Brain: Does It Improve Blood Flow and Cognition? | JACC Baran 41:56
  29. Acute PE in Practice: An APAC View on the New AHA/ACC Guideline | JACC Baran 42:19
  30. Marfan Syndrome: Timing Surgery Through Genetics | JACC Baran 36:28
  31. Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran 27:47
  32. Chagas Cardiomyopathy — Epidemiology Through Modern Clinical Trials | JACC Baran 19:47
  33. Japanese Circulation Society 2026 Special — JACC at #26JCS | JACC Baran 21:02
  34. Mild PVR in TAVR — A Small Leak, Long-Term Impact | JACC Baran 36:18
  35. LDH in HFrEF — A Common Test, A Hidden Signal | JACC Baran 35:59
  36. TAVR and HFrEF — Are We Fully Applying GDMT? | JACC Baran 26:56
  37. TR and AFib After M-TEER: A Risk Interaction to Watch | JACC Baran 42:55
  38. HFpEF: Normal by Echo, Abnormal by Hemodynamics | JACC Baran 30:53
  39. Cardiac Sarcoidosis Beyond Suppression: Imaging and Biomarkers That Matter | JACC Baran 37:15
  40. Coronary Revascularization in the Real World: Evidence, Policy, and Practice in Japan | JACC Baran 32:17
  41. What Spontaneous Echo Contrast Reveals After Left Atrial Appendage Closure | JACC Baran 24:48
  42. Too Old for Ablation? Insights from AF Patients Aged 80 and Above | JACC Baran 34:24
  43. Japan’s Cardiovascular Playbook: A Living History Book of Prevention | JACC Baran 40:21
  44. M-TEER: Challenging the Status Quo With Outcome-Driven Metrics | JACC Baran 29:36
  45. PREVENT in East Asia: Can One Risk Score Fit All? | JACC Baran 37:15
  46. “Just One Drink?” Think Again — Blood Pressure Says Bye to Alcohol | JACC Baran 34:38
  47. CT-Based Plaque Norms: Rethinking Risk in Healthy Adults | JACC Baran 29:00
  48. Leave Nothing Behind: The Current and Future of Drug-Coated Balloons in PCI | JACC Baran 38:43
  49. A Global Look at Heart Disease: What the GBD Study Reveals | JACC Baran 31:09
  50. Ten Seconds That Matter: Clinical Frailty Scale in Heart Failure | JACC Baran 29:21